Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|48|3|E232-E239

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.3, 2018-02, pp. : E232-E239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 536-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 537-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimum target prices for production of direct‐acting antivirals and associated diagnostics to combat hepatitis C virus

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1174-1182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 341-347

Karger

Access to resources Recommend Favorite

Treatment of hepatitis C: the use of the new pangenotypic direct‐acting antivirals in “special populations”

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 28-33

John Wiley & Sons Inc

Access to resources Recommend Favorite